Efficacy of Azelastine and Mometasone Irrigation in Comparison to Nasal Sprays in Patients With Chronic Rhinitis
Condition: Chronic Rhinitis Interventions: Drug: Azelastine (137 mcg/spray) Nasal Spray and Mometasone (50 mcg/spray) Nasal Spray; Drug: Mometasone Nasal Irrigation (1 mg capsule); Drug: Mometasone (1 mg) and Azelastine (1 mg) Nasal Irrigation Sponsor: NorthShore University HealthSystem Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 25, 2022 Category: Research Source Type: clinical trials
Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis.
Condition: Seasonal Allergic Rhinitis Interventions: Combination Product: Azelastine + Mometazone, nasal spray; Combination Product: Momat Rhino Advance Sponsor: Sandoz Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2022 Category: Research Source Type: clinical trials
